Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Associ...
Saved in:
| Published in: | The journal of clinical endocrinology and metabolism Vol. 101; no. 11; p. 3922 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.11.2016
|
| Subjects: | |
| ISSN: | 1945-7197, 1945-7197 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline.
The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies.
One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines.
Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use. |
|---|---|
| AbstractList | To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.OBJECTIVETo formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline.PARTICIPANTSThe participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline.The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies.EVIDENCEThe Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies.One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines.CONSENSUS PROCESSOne group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines.Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use.CONCLUSIONSContinuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use. To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline. The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies. One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use. |
| Author | Winter, William E Evert, Alison Wolpert, Howard Battelino, Tadej Peters, Anne L Murad, M Hassan Ahmann, Andrew J Hirsch, Irl B |
| Author_xml | – sequence: 1 givenname: Anne L surname: Peters fullname: Peters, Anne L organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 2 givenname: Andrew J surname: Ahmann fullname: Ahmann, Andrew J organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 3 givenname: Tadej surname: Battelino fullname: Battelino, Tadej organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 4 givenname: Alison surname: Evert fullname: Evert, Alison organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 5 givenname: Irl B surname: Hirsch fullname: Hirsch, Irl B organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 6 givenname: M Hassan surname: Murad fullname: Murad, M Hassan organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 7 givenname: William E surname: Winter fullname: Winter, William E organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 – sequence: 8 givenname: Howard surname: Wolpert fullname: Wolpert, Howard organization: Keck School of Medicine (A.L.P.), University of Southern California, Los Angeles, California 90033; Harold Schnitzer Diabetes Health Center (A.J.A.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (T.B.), University of Ljubljana and University Children's Hospital, 1104 Ljubljana, Slovenia; Endocrine and Diabetes Care Center (A.E., I.B.H.), University of Washington Medical Center, Seattle, Washington 98195; Mayo Clinic Evidence-based Practice Center (M.H.M.), Rochester, Minnesota 55905; UF Diabetes Institute (W.E.W.), University of Florida, Gainesville, Florida 32611; and Joslin Diabetes Center (H.W.), Harvard Medical School, Boston, Massachusetts 02115 |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27588440$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUD1PwzAUtFAR_YCNGXlkSbEdu07YqlJKpSKQWubIcV5aV6ld4njI3-GXEtQidbp7p7uT3g1RzzoLCN1TMqaMkqe9HjNCJxETMb9CA5pyEUmayt4F76Oh93tCKOcivkF9JkWScE4G6OfFqBwa8HgDemdd5bZtNHO2MTa44PE65Do0ysLfsbQ-VMZ2WAZvnMWbHdTq2GJlC3wRWlRBOw_43VnTuNrYLe5S0yJUjX_GU4vntnC60wGvnTbQtHjW9RqtKvxZK90YDXgRTAGdCrfoulSVh7szjtDX63wze4tWH4vlbLqKNJ8wGbEyVTGJCz7RaSxLmUOhmBAdS0pJZEKJAg4lFwkBXeZCyrhbhgidSs4LqdkIPZ56j7X7DuCb7GC8hqo6fZ_RJBY8JoLSzvpwtob8AEV2rM1B1W32vyv7BdeTfmo |
| CitedBy_id | crossref_primary_10_4103_ijem_IJEM_225_20 crossref_primary_10_1007_s11892_022_01490_z crossref_primary_10_1016_j_endien_2021_12_002 crossref_primary_10_1007_s13410_020_00819_2 crossref_primary_10_1177_19322968251331628 crossref_primary_10_2147_PGPM_S374663 crossref_primary_10_1136_bmj_2024_083865 crossref_primary_10_1016_j_ejphar_2018_04_002 crossref_primary_10_1080_17843286_2020_1837575 crossref_primary_10_1089_dia_2018_2502 crossref_primary_10_2337_dc22_S007 crossref_primary_10_2337_dc19_S007 crossref_primary_10_3390_jcm11123286 crossref_primary_10_1177_2042018819871903 crossref_primary_10_1111_imj_13770 crossref_primary_10_1016_j_diabres_2017_08_005 crossref_primary_10_1136_bcr_2021_245336 crossref_primary_10_1186_s40814_025_01607_7 crossref_primary_10_2337_dc19_0888 crossref_primary_10_2337_ds18_0091 crossref_primary_10_1186_s12902_024_01595_4 crossref_primary_10_1210_jc_2018_00275 crossref_primary_10_1210_clinem_dgaf074 crossref_primary_10_2337_dc16_2482 crossref_primary_10_2337_dc23_S007 crossref_primary_10_1111_jdi_13290 crossref_primary_10_2337_dc20_S007 crossref_primary_10_1210_js_2018_00294 crossref_primary_10_2337_dc18_1150 crossref_primary_10_1177_1932296820967004 crossref_primary_10_2337_ds18_0093 crossref_primary_10_1089_dia_2019_0041 crossref_primary_10_1089_dia_2018_0397 crossref_primary_10_1007_s13340_020_00488_w crossref_primary_10_1016_j_jclinepi_2021_11_009 crossref_primary_10_1111_pedi_13213 crossref_primary_10_1177_1932296820905577 crossref_primary_10_2337_dci19_0014 crossref_primary_10_1111_ajr_12440 crossref_primary_10_1007_s11892_017_0944_6 crossref_primary_10_1038_s41746_019_0202_1 crossref_primary_10_1177_19322968221128315 crossref_primary_10_1210_jendso_bvaf068 crossref_primary_10_2337_dci18_0002 crossref_primary_10_1002_edm2_252 crossref_primary_10_1002_jac5_70046 crossref_primary_10_1007_s12020_017_1328_z crossref_primary_10_1111_dme_13793 crossref_primary_10_1210_js_2018_00262 crossref_primary_10_1177_19322968211029303 crossref_primary_10_1016_j_japh_2021_05_013 crossref_primary_10_1177_19322968221139873 crossref_primary_10_1007_s13300_019_00728_6 crossref_primary_10_1177_19322968241268560 crossref_primary_10_1007_s13300_023_01366_9 crossref_primary_10_1177_2042018819865399 crossref_primary_10_1002_pdi_2215 crossref_primary_10_1089_dia_2021_0233 crossref_primary_10_2337_ds20_0103 crossref_primary_10_1016_j_endinu_2020_07_012 crossref_primary_10_3390_cells10092437 crossref_primary_10_2337_dc24_2222 crossref_primary_10_1007_s12020_020_02592_y crossref_primary_10_1136_bmjopen_2024_088785 crossref_primary_10_1177_0145721719894903 crossref_primary_10_3390_ijerph192416576 crossref_primary_10_1007_s11892_021_01375_7 crossref_primary_10_1016_S0140_6736_18_31320_5 crossref_primary_10_1177_26350106221120889 crossref_primary_10_1007_s13300_020_00831_z crossref_primary_10_1080_00325481_2019_1578590 crossref_primary_10_1177_19322968251313811 crossref_primary_10_1177_19322968221093355 crossref_primary_10_1016_j_endinu_2020_11_006 crossref_primary_10_1007_s11892_017_0905_0 crossref_primary_10_1016_S0140_6736_23_00223_4 crossref_primary_10_1111_1753_0407_13030 crossref_primary_10_1177_1932296821995810 crossref_primary_10_1016_j_hbpd_2018_08_005 crossref_primary_10_1089_dia_2019_0131 crossref_primary_10_3389_fendo_2023_1083145 crossref_primary_10_1002_jac5_1733 crossref_primary_10_1001_jamanetworkopen_2025_26353 crossref_primary_10_2337_dci17_0043 crossref_primary_10_1016_j_eprac_2021_04_008 crossref_primary_10_1016_j_ijpharm_2017_12_022 crossref_primary_10_1210_jendso_bvaf137 crossref_primary_10_1097_JXX_0000000000001060 crossref_primary_10_1097_MED_0000000000000840 crossref_primary_10_1038_s41574_018_0044_y crossref_primary_10_1089_dia_2021_0536 crossref_primary_10_1177_1932296818777265 crossref_primary_10_1002_pdi_2479 crossref_primary_10_1016_j_eprac_2023_04_007 crossref_primary_10_1210_jc_2019_00286 crossref_primary_10_1007_s00125_017_4463_4 crossref_primary_10_1210_js_2017_00388 crossref_primary_10_1007_s12325_019_0870_x crossref_primary_10_1089_dia_2017_0090 crossref_primary_10_1016_j_diabres_2020_108352 crossref_primary_10_4093_dmj_2019_0121 crossref_primary_10_1016_j_jcjd_2017_10_012 crossref_primary_10_1001_jama_2025_5956 crossref_primary_10_1111_dom_15059 crossref_primary_10_2337_dc25_S007 crossref_primary_10_1097_MJT_0000000000000667 crossref_primary_10_1007_s13300_021_01160_5 crossref_primary_10_1002_jimd_12383 crossref_primary_10_1007_s10730_020_09413_9 crossref_primary_10_1097_JXX_0000000000000659 crossref_primary_10_1016_j_endien_2021_11_009 crossref_primary_10_1177_0145721720978154 crossref_primary_10_1007_s13300_017_0294_z crossref_primary_10_2337_dc18_1581 crossref_primary_10_4158_EP_2018_0357 crossref_primary_10_1177_1932296819838292 crossref_primary_10_1002_cdt3_70018 crossref_primary_10_1089_dia_2020_0180 crossref_primary_10_2337_dci17_0065 crossref_primary_10_2337_dc24_S007 crossref_primary_10_1136_bmjopen_2020_046050 crossref_primary_10_1089_dia_2017_0021 crossref_primary_10_1089_dia_2021_0427 crossref_primary_10_1089_dia_2017_0141 crossref_primary_10_1007_s11606_023_08222_3 crossref_primary_10_1007_s11892_021_01415_2 crossref_primary_10_1007_s11845_023_03464_w crossref_primary_10_1089_dia_2017_0024 crossref_primary_10_1177_1932296818813581 crossref_primary_10_2196_41577 crossref_primary_10_1007_s00592_018_1147_6 crossref_primary_10_1093_her_cyae030 crossref_primary_10_1016_j_cmpb_2022_106905 crossref_primary_10_1001_jamanetworkopen_2023_54595 crossref_primary_10_2196_69061 crossref_primary_10_1002_dmrr_3152 crossref_primary_10_1089_dia_2017_0035 crossref_primary_10_1210_jc_2018_00526 crossref_primary_10_2337_dc21_S007 crossref_primary_10_7326_AITC202203150 crossref_primary_10_1007_s11892_019_1177_7 crossref_primary_10_1016_j_jand_2018_03_007 crossref_primary_10_1007_s13300_017_0255_6 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1210/jc.2016-2534 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1945-7197 |
| ExternalDocumentID | 27588440 |
| Genre | Journal Article Practice Guideline |
| GroupedDBID | --- -~X .55 .GJ .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 3O- 4.4 48X 53G 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABZA AACZT AAIMJ AAJQQ AAKAS AAPGJ AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABBLC ABDFA ABDPE ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABUWG ABVGC ABWST ABXVV ABXZS ACFRR ACGFO ACGFS ACPRK ACUTJ ACVCV ACYHN ACZBC ADBBV ADGKP ADGZP ADHKW ADMTO ADNBA ADQBN ADRTK ADVEK ADZCM AELWJ AEMDU AEMQT AENEX AENZO AEOTA AERZD AETBJ AEWNT AFCHL AFFNX AFFQV AFFZL AFGWE AFKRA AFOFC AFRAH AFXAL AFYAG AGINJ AGKRT AGMDO AGORE AGQXC AGUTN AHGBF AHMBA AHMMS AI. AJBYB AJDVS AJEEA ALMA_UNASSIGNED_HOLDINGS ALXQX APIBT APJGH AQDSO AQKUS ARIXL ASPBG ATGXG AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BENPR BEYMZ BPHCQ BSWAC BTRTY BVXVI C45 CCPQU CDBKE CGR CS3 CUY CVF D-I DAKXR DIK E3Z EBS ECM EIF EIHJH EJD EMOBN ENERS F5P FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FYUFA GAUVT GJXCC GX1 H13 HMCUK HVGLF HZ~ H~9 IAO IHR INH ITC J5H KBUDW KOP KSI KSN L7B M1P M5~ MBLQV MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NPM NU- NVLIB O9- OAUYM OBFPC OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO REU ROX ROZ TEORI TJX TLC TMA TR2 TWZ UKHRP VH1 VVN W8F WHG WOQ X52 X7M YBU YFH YHG YOC YSK ZGI ZXP ZY1 ~02 ~H1 7X8 AEHZK |
| ID | FETCH-LOGICAL-c4627-2f9a303d46c937f7beda2557f78f707810ae4ef4580ecfb577319705c9744d7c2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 135 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00004678-201611000-00007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1945-7197 |
| IngestDate | Wed Oct 01 14:04:06 EDT 2025 Mon Jul 21 06:03:30 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4627-2f9a303d46c937f7beda2557f78f707810ae4ef4580ecfb577319705c9744d7c2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Instructional Material/Guideline-3 content type line 23 |
| PMID | 27588440 |
| PQID | 1835430511 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1835430511 pubmed_primary_27588440 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-Nov 20161101 |
| PublicationDateYYYYMMDD | 2016-11-01 |
| PublicationDate_xml | – month: 11 year: 2016 text: 2016-Nov |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The journal of clinical endocrinology and metabolism |
| PublicationTitleAlternate | J Clin Endocrinol Metab |
| PublicationYear | 2016 |
| References | 36752561 - J Clin Endocrinol Metab. 2023 Feb 08 |
| References_xml | – reference: 36752561 - J Clin Endocrinol Metab. 2023 Feb 08;: |
| SSID | ssj0014453 |
| Score | 2.5948083 |
| SecondaryResourceType | review_article |
| Snippet | To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.... To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 3922 |
| SubjectTerms | Adult Blood Glucose - analysis Combined Modality Therapy - adverse effects Combined Modality Therapy - trends Consensus Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - diet therapy Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 1 - therapy Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diet therapy Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - therapy Diet, Diabetic - adverse effects Drug Monitoring - trends Endocrinology - methods Evidence-Based Medicine Exercise Humans Hyperglycemia - prevention & control Hypoglycemia - chemically induced Hypoglycemia - prevention & control Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Insulin - administration & dosage Insulin - adverse effects Insulin - therapeutic use Insulin Infusion Systems - adverse effects Insulin Infusion Systems - trends International Agencies Monitoring, Ambulatory - adverse effects Monitoring, Ambulatory - trends Patient Education as Topic Precision Medicine Societies, Scientific |
| Title | Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27588440 https://www.proquest.com/docview/1835430511 |
| Volume | 101 |
| WOSCitedRecordID | wos00004678-201611000-00007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3IvgabLukaX2RIdv0YWMPE_ZW2jSBiXTTWn-Qv9Rzkoz5Igi-9AINtOnJyXdu3yHkpshLBTCjw7gGE4ULHbACmRGTUiCCTqXmyjabkKNRMp2mY-9wq31a5VInWkVdzhX6yG9D9FCAcIbh_eKNYdcojK76FhrrpNUBKINSLaerKALnloUS7HTBZJhKn_iOVSsvSF8YxiwS2DL5N3BpN5n-7n9fb4_seHhJu04e9smarg7I1tAH0A_Jl8-AqenKp86QoWpWNfOmpqBHVAN4UePNk8tTh7Np0KlGJ46CgOZVSX8MGri0d-r0AzoKKYzqIrNHfUe7Fe1V8AFYZkh9kij1dKSvdOyrtOigQcIteOaIPPd7k4dH5ts0MMXjSLLIpDlshCWPFWAdIwtd5mCowFViLJdQkGuuDRdJoJUphJSw7GUgFJgyvJQqOiYb1bzSp4RKWQKihG1bFmCyizTRqtCB5jG2yjKm0ybXy9nPYBlgbMPNSLaa_zY5cb8wWzi-jiySWI3Lg7M_jD4n21YubLXhBWkZUAL6kmyqz49Z_X5l5QuOo_HwGyck3Q0 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diabetes+Technology-Continuous+Subcutaneous+Insulin+Infusion+Therapy+and+Continuous+Glucose+Monitoring+in+Adults%3A+An+Endocrine+Society+Clinical+Practice+Guideline&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Peters%2C+Anne+L&rft.au=Ahmann%2C+Andrew+J&rft.au=Battelino%2C+Tadej&rft.au=Evert%2C+Alison&rft.date=2016-11-01&rft.eissn=1945-7197&rft.volume=101&rft.issue=11&rft.spage=3922&rft_id=info:doi/10.1210%2Fjc.2016-2534&rft_id=info%3Apmid%2F27588440&rft_id=info%3Apmid%2F27588440&rft.externalDocID=27588440 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1945-7197&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1945-7197&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1945-7197&client=summon |